Large-scale testing (Phase 3)Study completedNCT01151098
What this trial is testing
Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study
Who this might be right for
Chronic Nonmalignant Pain
Purdue Pharma LP 189